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hlamydial infections are the mostcommon bac-
terial STD in the United States, with an esti-
mated annual incidence of 4 million cases and costs
in excess of $2 billion. Pelvic inflammatory disease
(PID) (i.e., acute salpingitis) is frequently a conse-
quence of sexually transmitted diseases, including
gonococcal, mycoplasmal, and chlamydial infection,
and is usually the result of progression of disease
from the lower to the upper reproductive tract. Ap-
proximately million women are treated for PID
in the United States annually, and one-quarter of
these women are affected with serious sequelae,
including ectopic pregnancy and tubal infertility.
As many as half of these PID cases are caused by
chlamydiae. Such infections are now recognized as
a major public health problem. However, a limited
understanding of the immuno-pathogenesis of PID
still exists. This has been due in part to the limited
number of clinical specimens available for study
and the continued need to develop appropriate and
suitable animal models in which to study Ch/amydia
trachomatis in particular.
1-4
PIG-TAILED MACAQUE CERVICAL
INOCULATION MODEL
For the past decade, we have used pig-tailed mon-
keys to study the pathogenesis of chlamydial cervi-
citis and salpingitis. Since the normal reproductive
biology of the pig-tailed monkey is well defined,
we anticipated that this model would be useful for
functional studies following induction of cervicitis
and salpingitis and for easily recognizing abnormal
morphology in infected animals. Initially, our stud-
ies were designed to determine whether the pig-
tailed monkey would be an appropriate animal
model in which to study the pathogenesis of chla-
mydial cervicitis and salpingitis. As described be-
low, the immune responses and histopathologic
characteristics of chlamydial infection in this model
mimic human cervicitis and salpingitis, although
only limited data in humans are available. Thus,
we have continued to use the pig-tailed monkey
model to evaluate C. trachomatis infection in the
lower and upper genital tracts.
Repeated Cervical Inoculation With
C. trachomatis After Culture-Negative Intervals
Seven pig-tailed macaques were inoculated in the
cervix with a serovar D strain, while 3 control mon-
keys were cervically inoculated with uninfected
McCoy cells only. The animals that received viable
C. tracaomatis were than reinoculated, but only after
2 to 3 consecutive weeks of culture-negative speci-
mens. After spontaneous cessation of cervical shed-
ding of C. trachomatis, repeated inoculation either
failed to produce infection or resulted in infection
of shorter duration with lower inclusion counts.
Thus, the initial cervical infection persisted for 1-15
weeks (average, 9.3 weeks), while reinoculation of
the cervix failed in 3 of 7 animals, and among the
4 animals who were infected, persisted only 4.8
weeks on average. Among 2 animals infected a third
time, the third infection averaged 1.5 weeks. The
highest chlamydial inclusion count in primary infec-
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tions was not reached until after 5 weeks in 3 ani-
mals, and after 12-13 weeks in the other 3. In
animal the culture was positive on one occasion
only. In contrast, the maximum inclusion count
after the second inoculation was much reduced as
compared with those after initial infection. Laparos-
copy after the initial infection showed uterine ery-
thema in of 4 animals and in all animals after
the second cervical inoculation with C. trachomatis.
Tubal edema was also a frequent observation, but
tubal cultures were consistently negative. No peri-
tubal or periadnexal adhesions were observed dur-
ing this experiment. In conclusion, after repeated
cervical inoculations given when cervical shedding
had ceased prior to rechallenge, either no infection
developed or an infection of shorter duration was
produced, suggesting that partially protective im-
munity occurred at the level ofthe cervix. Induction
of tubal scarring or adhesions was not observed.
Acute Salpingitis Induced by Repeated Weekly
Cervical Inoculations of C. trachomatis
Because upper tract disease was not observed fol-
lowing repeated cervical inoculations, we increased
the frequency of the cervical inoculations to once
weekly for 5 weeks. A serovar D strain was used
and 3 monkeys were studied. Laparoscopies and
videomicroscopy were performed at weekly inter-
vals to assess gross morphology and the presence of
C. tarchomatis by culture of the cervix and fallopian
tubes. After initial inoculation, chlamydia was reiso-
lated from the cervix in all 3 monkeys and uterine
erythema occurred in 2 of 3 monkeys. After 3 weeks
of cervical inoculations, mild omental and peritubal
adhesions developed in monkey and severe peri-
tubal and omental adhesions developed in another
monkey. In this latter monkey, chlamydia was iso-
lated from the fallopian tube at the time of the
fourth laparoscopy. Plasma cell cervicitis, endome-
tritis and salpingitis were also documented in this
particular monkey. We conclude from these experi-
ments that upward migration of chlamydia from the
cervix into the fallopian tube occurred and pro-
duced acute salpingitis similar to that observed in
women.
Repeated Cervical Infection Followed by a
Single Tubal Challenge with C. trachomatis
In a subsequent series of experiments, we tested
the hypothesis that more severe tubal disease could
be induced if the animal first received repeated
cervical inoculations, followed by direct inoculation
of the fallopian tube. Eleven pig-tailed macaques
were cervically inoculated between 2 and 5 times
with C. trachomatis serovars D and F. Fallopian
tubes were then inoculated with serovar D or F
week after the last cervical inoculation. In addition,
three control monkeys received direct tubal inocu-
lation without previous cervical inoculation. The
production of cervical infection was confirmed by
isolating C. trachomatis from the endocervix in 13
of 14 monkeys. Chlamydia was isolated from the
endosalpinx in four animals, but only after the tubal
inoculation. Antibody to C. trachomatis was detected
in post-infection sera of all 14 animals. Tubal edema
occurred in 7 of 11 animals after the first cervical
inoculation, and uterine erythema occurred in all 11
after the second cervical inoculation. Before tubal
inoculation, peritubal adhesions were present in 0
of 7 monkeys given 3 or fewer cervical inoculations
vs. all 4 given 5 cervical inoculations (p <.01). After
direct tubal inoculation, however, peritubal adhe-
sions became more prominent. Hysterectomy speci-
mens were obtained from 11 animals, of which 9
had plasma cell endometritis and 9 had salpingitis.
Two control monkeys developed minor adhesions,
while the other had none. One fallopian tube in 2
of the 3 controls showed mild plasma cell infiltrates,
but no evidence of endometritis was observed in
the controls. The histopathologic findings in these
monkeys were characteristic of chlamydial cervici-
tis, endometritis, and salpingitis in humans.
In summary, the major findings of interest in this
study included: 1) frequent production of uterine
erythema, tubal edema, and peritubal adhesions fol-
lowing repeated cervical infection; and 2) produc-
tion of endometritis and endosalpingitis following
tubal infection, with or without prior cervical infec-
tion. In the absence of direct tubal inoculation, de-
velopment ofperitubal adhesions required 5 weekly
cervical inoculations.
Mediators of Inflammation Associated With
Scarring and Fibrosis
The spectrum ofcytokines expressed during persis-
tent infection with C. trachomatis has not been de-
scribed. Studies to determine the cytokine mRNA
profile in infected target tissues were carried out to
help characterize the local immune response oc-
curring in chronically-infected fallopian tubes, the
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TABLE I. Cytokine mRNA in tubes detected by RT-PCR in 6 week C. trachomatis-infected macaques (n 2)
and in uninfected macaques (n 3)*
Infected #1 Infected #2 Uninfected #1 Uninfected #2 Uninfected #3
IFN-y 3+ 3+ +/-
IL-4
IL-5 +/- +/- +/- +/-
IL-6 3+ 3+ +/- +/-
IL-10 I+ 2+
PDGF-[3 2+ 2+
TGF-[3 3+ 4+ +/- I/
*Each sample was semi-quantitatively scored for the PCR product for each cytokine. Samples scored as 3+ had the most cytokine PCR product, 2+
and + successively less quantitites ofPCR product, while +/- mean the PCR product was barely detectable, and meant the PCR product was absent.
tissue most damaged by C. trachomatis infection.
The cytokines expressed in C. trachomatis-infected
tissues were detected using reverse transcriptase
combined with polymerase chain reaction (RT-
PCR). A series of oligonucleotides were developed
that detected IFN-y, IL-4, IL-5, IL-6, IL-10,
PDGF-13 and TGF-[3 mRNA by RT-PCR from
RNA extracted from mitogen-stimulated macaque
peripheral blood mononuclear cells. The quantity
ofcDNA in each tissue was normalized for constitu-
tive mRNA for hypoxanthine phosphoribosyl trans-
ferase using quantitative competitive PCR. Semi-
quantitative PCR was used to determine the rela-
tive quantity of selected cytokine mRNA. Macaque
fallopian tubes infected for 6 and 12 week durations
were studied. The 12 week infected tubes were
found to have no increase in cytokine mRNA com-
pared with uninfected controls (data not shown).
This correlated with histologic findings ofend stage
fibrosis and scarring with relatively few inflamma-
tory cells present. It seems likely that the synthesis
of cytokines related to the production of fibrosis
and scarring preceded the 12 week end point. This
hypothesis was supported by detection of cytokine
mRNA for IFN-y, IL-6, I1-10, PDGF-13 and TGF-
13, but not IL-4 and IL-5, in increased quantities
in the 6 week infected tubes vs. unifected tubes
(Table 1). This correlated with a much more active
cellular infiltration in the 6 week than in the 12
week infected tubes, including the presence of nu-
merous lymphocytes and macrophages. The finding
of IFN-y production in the absence of detectable
IL-4 and IL-5 production suggested that Thl type
cytokines dominate the chronic immune response
to C. trachomatis infection in tubes. Though Thl
responses generally help control intracellular patho-
gens, exaggeration ofThl responses due to a persis-
tent pathogen may lead to scarring and fibrosis.
The presence ofPDGF-I3 and TGF-I3 mRNA in
6 week infected tubes suggests that these mediators
may be involved in the generation of tubal fibrosis
and scarring. Both PDGF-13 and TGF-13 are gener-
ally derived from macrophages during an inflamma-
tory response. 1’11 Both ofthese cytokines have been
implicated in processes leading to fibrosis and inter-
ference with TGF-[3 function has been shown to
prevent scarring in a glomerulonephritis model,
lqz
Studies have been initiated to confirm these re-
suits using cytokine detection assays. IFN-y was
detected using ELISA in the peritoneal fluid of 78
of 11 chronically-infected macaques but in none of
2 uninfected control macaques (Table 2). IL-6 was
detected using the B9 bioassay
3 in peritoneal fluid
of 6 of 8 chronically infected animals, but in 0 of 2
uninfected controls. IL-10 was detected by ELISA
in peritoneal fluids of 7 of 11 infected animals but
in neither of the 2 uninfected macaques. These
results confirm some of the findings from the RT-
PCR assay of cytokine mRNA. Since both IL-6 and
IL-10 are produced by both Thl and Th2 CD4
/
T cells in humans, 14 both cytokines could be pro-
duced by both types of CD4
/ T cells in macaques.
Since IL-4 and IL-5 mRNA could not be detected
by RT-PCR, it seems likely that the IFN-y, IL-6,
and IL-10 are produced by a predominantly Thl
immune response, though further studies are neces-
sary to confirm this hypothesis. The high levels of
IL-10 found are of interest, because IL- 10 has been
shown to antagonize the killing of intracellular
pathogens by IFN- activated macrophages. Thus,
high levels of IL-10 may be associated with persis-
tence of C. trachomatis.
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TABLE 2. Presence of cytokines in peritoneal fluids of infected and uninfected macaques*
IFN-y (IU/ml) IL-6 (pg/ml) IL-10 (pg/ml)
+/total range mean +/total range mean +/total range mean
Ct inf 7/11 <2 >50 >20 6/8 <10- 157 7/10 <200- 3966
macaques macaques 420 macaques 14,000
No Ct 0/2 <2 <2 0/2 < 10 < 10 0/2 <200 <200
macaques macaques macaques
*Ct-inf peritoneal fluid from C. trachomatis infected macaques taken at 2 or 4 weeks after infection; No Ct- peritoneal fluid from uninfected
macaques; +/total the number of samples that exceed the lower detection limit for the cytokine/the number of samples tested.
SUMMARY
Our understanding of the pathogenesis ofchlamyd-
ial PlD/salpingitis and its sequelae is minimal. Cur-
rent knowledge of the pathogenesis has been de-
rived primarily from nonhuman primate and small
animal experimental models because comprehen-
sive data and reproductive tract tissues from women
are limited. We have utilized the pig-tailed ma-
caque in situ model to study the natural history and
mechanisms of pathogenesis of chlamydial lower
and upper genital tract infections. More recently,
the direction of our research has focused on the
immune response and immunopathology associated
with C. trachomatis tubal disease. Continued studies
will advance our understanding of scarring and fi-
brosis associated with human genital tract chlamyd-
ial infections and may lead to the prevention of its
sequelae, tubal infertility and ectopic pregnancy.
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